An open-label randomized controlled trial evaluating the efficacy of chloroquine/hydroxychloroquine in severe COVID-19 patients

Despite several studies designed to evaluate the efficacy of chloroquine and hydroxychloroquine in the treatment of coronavirus disease 2019 (COVID-19), there is still doubt about the effects of these drugs, especially in patients with severe forms of the disease. This randomized, open-label, contro...

Descripción completa

Detalles Bibliográficos
Autores principales: Réa-Neto, Álvaro, Bernardelli, Rafaella Stradiotto, Câmara, Bruna Martins Dzivielevski, Reese, Fernanda Baeumle, Queiroga, Marcos Vinicius Oliveira, Oliveira, Mirella Cristine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079411/
https://www.ncbi.nlm.nih.gov/pubmed/33907251
http://dx.doi.org/10.1038/s41598-021-88509-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079411/
https://www.ncbi.nlm.nih.gov/pubmed/33907251
http://dx.doi.org/10.1038/s41598-021-88509-9

Ejemplares similares